Table 1.
MDRGN, ESBL, and CRGN associated BSIs frequency among most common gram-negative bacteria as well as MRSA and MRCoNS among gram-positive associated BSIs during 2015–2019
| 2015 n (%) |
2016 n (%) |
2017 n (%) |
2018 n (%) |
2019 n (%) |
p-value | ||
|---|---|---|---|---|---|---|---|
| MDR | 20 (40) | 36 (50) | 53 (49.5) | 66 (53.75) | 29 (46.8) | 0.588 | |
| E. coli | 12 (60) | 22 (61.1) | 26 (49.1) | 13 (19.7) | 18 (62.1) | ||
| K. pneumoniae | 3 (15) | 3 (8.3) | 4 (7.5) | 9 (13.6) | 5 (17.2) | ||
| Acinetobacter spp. | 2 (10) | 3 (8.3) | 2 (3.8) | 0 (0) | 0 (0) | ||
| Pseudomonas spp. | 1 (5) | 6 (16.7) | 18 (34) | 43 (65.2) | 6 (20.7) | ||
| ESBL | 5 (15.2) | 31 (46.3) * | 43 (43) * | 66 (55.5) | 28 (45.9) | 0.002 | |
| E. coli | 5 (100) | 18 (75) | 20 (60.6) | 14 (82.4) | 13 (50) | ||
| K. pneumoniae | 0 (0) | 3 (15) | 4 (16) | 7 (33.3) | 6 (31.6) | ||
| Acinetobacter spp. | 0 (0) | 2 (100) | 3 (100) | 0 (0) | 0 (0) | ||
| Pseudomonas spp. | 0 (0) | 6 (100) | 15 (88.2) | 45 (97.8) | 9 (100) | ||
| CRGN | 15 (14.9) | 17 (16.8) | 23 (22.8) | 42 (41.6) | 4 (4) | < 0.0001 | |
| E. coli | 11 (84.6) | 11 (40.7) | 5 (13.9) | 3 (14.3) | 0 (0) | ||
| K. pneumoniae | 2 (66.7) | 2 (40) | 0 (0) | 1 (7.1) | 0 (0) | ||
| Acinetobacter spp. | 1 (33.3) | 3 (100) | 3 (100) | 0 (0) | 0 (0) | ||
| Pseudomonas spp. | 0 (0) | 1 (16.7) | 15 (75) | 38 (82.6) | 4 (44.4) | ||
| MRSA | 0 (0) | 3 (50) | 1 (25) | 0 (0) | 0 (0) | 0.038 | |
| MR-CONS | 13 (86.7) | 7 (53.8) | 13 (92.9) | 22 (78.6) | 5 (62.5) | 0.112 |
MDRGN: multidrug-resistant gram-negative bacteria; ESBL: extended-spectrum beta-lactamases (ESBL)-producing gram-negative bacteria; CRE: carbapenem-resistant Enterobacterales; CRGN: carbapenem-resistant gram-negative bacteria; MRCONS: methicillin-resistant coagulase-negative Staphylococci; MRSA: methicillin-resistant Staphylococcus aureus. P-values marked with bold indicate statistically significant p-values